Understanding Diabetes: Why Treatment Isn’t One-Size-Fits-All

Diabetes presents in multiple forms, but its management is never uniform. In Korea, patient lifestyles and national health policies further influence how treatment is selected.

Type 1 Diabetes: An autoimmune condition that destroys insulin-producing cells in the pancreas. Daily insulin injections are required for survival. This type is less common in Korea but typically begins in youth.
Type 2 Diabetes: A metabolic condition more prevalent in Korea's aging population. It stems from insulin resistance and is often influenced by diet, weight, and inactivity.

"Even two patients with the same A1C score can need totally different regimens depending on how their body responds, what they eat, and their job stress," explains Dr. Yoo Du-yeol, a seasoned internist at Sangdo Woori Internal Medicine in Seoul.

Dr. Yoo’s Approach: How Medication Choices Are Made in Korea

At Sangdo Woori Internal Medicine, Dr. Yoo Du-yeol combines internationally recognized diabetes care guidelines with practical experience rooted in the lives of Korean patients. His approach is not just clinical—it’s personal, adaptive, and grounded in how people actually live.

Key Elements of Dr. Yoo’s Protocol:

Quarterly A1C Testing
To monitor long-term glucose control and adjust medications proactively if targets aren’t met.
Real-Life Functional Assessments
Evaluating how blood sugar responds during mealtimes, work stress, commuting, or even family routines helps guide fine-tuned treatment.
Side Effect Monitoring Beyond Labs
Dr. Yoo emphasizes patient logs, in-person conversations, and follow-up visits to catch side effects that may not show up in blood work—like fatigue, digestive discomfort, or dizziness.

“I recall a retired teacher who cooked every meal but had fluctuating sugar levels. We discovered her weekend snacking habits were the issue—not her meds. Tailoring advice around real life is where good care starts,” shares Dr. Yoo.

This kind of nuanced understanding is what makes Dr. Yoo’s care stand out—medication decisions are not just about numbers, but about context.

Core Factors That Shape Diabetes Medication Plans

No medication plan is designed in isolation. At Sangdo Woori, several variables are carefully evaluated:

1. Blood Sugar Targets

Morning (fasting) and 2-hour post-meal glucose readings matter just as much as A1C.
Ideal A1C for most Korean adults: below 7%; some older patients may have a more lenient target depending on frailty and risks.

2. Age and Physical Profile

Seniors: More sensitive to hypoglycemia, so medications like DPP-4 inhibitors or basal insulin are safer.
Younger or overweight adults: GLP-1 receptor agonists or SGLT2 inhibitors can aid weight loss and offer cardiovascular protection.

3. Kidney and Liver Function

Blood and urine tests help determine if medications like metformin or SGLT2 inhibitors are safe.
NHIS reimbursement criteria often change based on renal function stages, impacting access to newer therapies.

4. Affordability in Korea

Generic versions of metformin and sulfonylureas are widely covered under NHIS.
SGLT2 and GLP-1 agents, while effective, can be costly and may require approval paperwork.

"Many patients are surprised to learn that coverage doesn’t just depend on the drug—it depends on their labs," Dr. Yoo notes.

Medication Snapshot: What Patients in Korea Commonly Use

Here’s how common diabetes medications compare based on Dr. Yoo’s experience and NHIS trends:

Medication Type	Example Drug	Pros	Cons
Metformin	Glucophage	First-line, low-cost, improves sensitivity	GI discomfort in some
Sulfonylureas	Glimepiride	Affordable, fast-acting	Hypoglycemia, possible weight gain
SGLT2 Inhibitors	Dapagliflozin	Promotes weight loss, heart/kidney benefit	UTI risk, dehydration, costly
GLP-1 Receptor Agonists	Semaglutide	Appetite suppression, A1C reduction	Injectable, expensive
DPP-4 Inhibitors	Sitagliptin	Safe for elderly, well-tolerated	Mild effect, limited impact on weight
Insulin	Lantus, NovoRapid	Precise control for advanced cases	Daily injections, risk of low sugar

"We’ve had success combining a GLP-1 with basal insulin in overweight patients—it gives tight control with fewer total injections," Dr. Yoo adds.

When to Adjust or Combine Medications

Diabetes medication regimens are not static—they evolve alongside a patient’s condition, lifestyle, and response to treatment. Dr. Yoo Du-yeol frequently adjusts plans based on both clinical indicators and patient feedback.

Common Reasons for Medication Adjustment:

Treatment Plateau: If A1C levels don’t improve within 3–6 months, another drug class may be introduced.
Tolerability Issues: Side effects such as nausea, gastrointestinal discomfort, or urinary frequency may require a medication change.
Organ Function Decline: Changes in kidney or liver function prompt dosage adjustments or medication substitution.
Hypoglycemia Episodes: Frequent low blood sugar, especially in older adults, signals the need for reevaluation.

“Combination therapy isn’t a failure—it’s how we match medications to body needs more precisely,” says Dr. Yoo Du-yeol.

Beyond Pills: Supporting Medication with Lifestyle

Medication alone is not enough. Dr. Yoo emphasizes that lasting success in diabetes care requires practical lifestyle changes integrated into daily routines.

Diet and Nutrition

Favor low glycemic Korean-style meals: brown rice, tofu, seaweed soup, non-starchy vegetables.
Minimize sugary sauces, instant noodles, and processed snacks that spike blood sugar.

Physical Activity

Aim for 150 minutes of moderate exercise weekly—even brisk walking to the local market counts.
For those with busy schedules, short 10-minute movement breaks throughout the day can improve insulin sensitivity.

Stress and Sleep

Chronic stress raises cortisol, which worsens blood sugar control.
Dr. Yoo recommends guided breathing apps, evening walks, or calming routines to reduce stress.
Prioritizing consistent sleep helps regulate blood sugar and hormone levels.

Digital Tools

Use mobile apps to track glucose, log meals, and set medication reminders.
NHIS offers partial reimbursement for continuous glucose monitoring (CGM) devices in eligible patients.

Real Questions from Korean Patients

Q: Will I need insulin forever if I start it?
A: Not always. Some patients can scale back or discontinue insulin once lifestyle changes and oral medications stabilize their blood sugar.

Q: What’s the most affordable option under NHIS?
A: Metformin, glimepiride, and older insulins like NPH are well-supported. With accurate documentation, co-pays are minimal.

Q: Can medications also help with weight?
A: Yes. Medications like GLP-1 receptor agonists and SGLT2 inhibitors can aid both blood sugar control and weight loss, especially in patients with obesity.

Q: How does Dr. Yoo monitor progress?
A: In addition to lab results, Dr. Yoo evaluates digital logs, asks about energy levels, and performs routine checks on foot sensation and eye health.

Q: What if my lifestyle makes strict meal times difficult?
A: Extended-release medications or once-daily injections offer flexibility. Dr. Yoo tailors regimens to shift workers, teachers, delivery drivers, and others with nontraditional schedules.

Final Thoughts from Dr. Yoo

"Choosing diabetes medication isn’t about fitting into a box—it’s about designing a box that fits you. That’s our philosophy," says Dr. Yoo Du-yeol, internal medicine specialist at Sangdo Woori Internal Medicine.

Managing diabetes effectively means more than just following textbook guidelines. It requires an understanding of each patient's daily reality, lifestyle, and long-term goals. At Sangdo Woori, treatment plans are tailored using the latest clinical evidence, full awareness of NHIS (National Health Insurance Service) coverage, and a deep respect for each individual's circumstances.

Whether you’ve been newly diagnosed or are exploring better options after years of managing the disease, Dr. Yoo provides thoughtful, data-driven guidance—delivered with compassion and a commitment to your well-being.